Myeloid-derived suppressor cells

Their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets

Ibrahim H. Younos, Fuminori Abe, James E. Talmadge

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells at various stages of differentiation/maturation that have a role in cancer induction and progression. They function as vasculogenic and immunosuppressive cells, utilizing multiple mechanisms to block both innate and adaptive anti-tumor immunity. Recently, their mechanism of action and clinical importance have been defined, and the cross-talk between myeloid cells and cancer cells has been shown to contribute to tumor induction, progression, metastasis and tolerance. In this review, we focus on the role of MDSCs in hematologic malignancies and the therapeutic approaches targeting MDSCs that are currently in clinical studies.

Original languageEnglish
Pages (from-to)2251-2263
Number of pages13
JournalLeukemia and Lymphoma
Volume56
Issue number8
DOIs
Publication statusPublished - Aug 3 2015

Fingerprint

Hematologic Neoplasms
Myeloid Cells
Neoplasms
Therapeutics
Immunosuppressive Agents
Immunity
Neoplasm Metastasis
Myeloid-Derived Suppressor Cells
Population

Keywords

  • hematologic malignancies
  • leukemia
  • lymphoma
  • multiple myeloma
  • Myeloid-derived suppressor cells

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Myeloid-derived suppressor cells : Their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets. / Younos, Ibrahim H.; Abe, Fuminori; Talmadge, James E.

In: Leukemia and Lymphoma, Vol. 56, No. 8, 03.08.2015, p. 2251-2263.

Research output: Contribution to journalReview article

@article{c9c36be845314f2d9cfbb7a6be5f77b0,
title = "Myeloid-derived suppressor cells: Their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets",
abstract = "Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells at various stages of differentiation/maturation that have a role in cancer induction and progression. They function as vasculogenic and immunosuppressive cells, utilizing multiple mechanisms to block both innate and adaptive anti-tumor immunity. Recently, their mechanism of action and clinical importance have been defined, and the cross-talk between myeloid cells and cancer cells has been shown to contribute to tumor induction, progression, metastasis and tolerance. In this review, we focus on the role of MDSCs in hematologic malignancies and the therapeutic approaches targeting MDSCs that are currently in clinical studies.",
keywords = "hematologic malignancies, leukemia, lymphoma, multiple myeloma, Myeloid-derived suppressor cells",
author = "Younos, {Ibrahim H.} and Fuminori Abe and Talmadge, {James E.}",
year = "2015",
month = "8",
day = "3",
doi = "10.3109/10428194.2014.987141",
language = "English",
volume = "56",
pages = "2251--2263",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Myeloid-derived suppressor cells

T2 - Their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets

AU - Younos, Ibrahim H.

AU - Abe, Fuminori

AU - Talmadge, James E.

PY - 2015/8/3

Y1 - 2015/8/3

N2 - Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells at various stages of differentiation/maturation that have a role in cancer induction and progression. They function as vasculogenic and immunosuppressive cells, utilizing multiple mechanisms to block both innate and adaptive anti-tumor immunity. Recently, their mechanism of action and clinical importance have been defined, and the cross-talk between myeloid cells and cancer cells has been shown to contribute to tumor induction, progression, metastasis and tolerance. In this review, we focus on the role of MDSCs in hematologic malignancies and the therapeutic approaches targeting MDSCs that are currently in clinical studies.

AB - Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells at various stages of differentiation/maturation that have a role in cancer induction and progression. They function as vasculogenic and immunosuppressive cells, utilizing multiple mechanisms to block both innate and adaptive anti-tumor immunity. Recently, their mechanism of action and clinical importance have been defined, and the cross-talk between myeloid cells and cancer cells has been shown to contribute to tumor induction, progression, metastasis and tolerance. In this review, we focus on the role of MDSCs in hematologic malignancies and the therapeutic approaches targeting MDSCs that are currently in clinical studies.

KW - hematologic malignancies

KW - leukemia

KW - lymphoma

KW - multiple myeloma

KW - Myeloid-derived suppressor cells

UR - http://www.scopus.com/inward/record.url?scp=84941897868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941897868&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.987141

DO - 10.3109/10428194.2014.987141

M3 - Review article

VL - 56

SP - 2251

EP - 2263

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 8

ER -